These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22796924)

  • 1. Screening health care workers with interferon-γ release assay versus tuberculin skin test: impact on costs and adherence to testing (the SWITCH study).
    Wrighton-Smith P; Sneed L; Humphrey F; Tao X; Bernacki E
    J Occup Environ Med; 2012 Jul; 54(7):806-15. PubMed ID: 22796924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of cost and cost-effectiveness of different TB-screening strategies.
    Nienhaus A; Schablon A; Costa JT; Diel R
    BMC Health Serv Res; 2011 Sep; 11():247. PubMed ID: 21961888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-placement screening for tuberculosis in healthcare workers.
    Giri P; Basu S; Sargeant T; Rimmer A; Pirzada O; Adisesh A
    Occup Med (Lond); 2014 Oct; 64(7):524-9. PubMed ID: 25135937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal.
    Sousa S; Rocha D; Silva JC; Ribeiro AI; Gonçalves G; Almeida Á; Correia AM; Duarte R; Carvalho C
    Pulmonology; 2021; 27(6):493-499. PubMed ID: 34053903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
    del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis screening of new hospital employees: compliance, clearance to work time, and cost using tuberculin skin test and interferon-gamma release assays.
    Foster-Chang SA; Manning ML; Chandler L
    Workplace Health Saf; 2014 Nov; 62(11):460-7. PubMed ID: 25207587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis.
    Ang M; Nguyen HV; Kiew SY; Chen S; Chee SP; Finkelstein E
    Br J Ophthalmol; 2015 Jul; 99(7):984-9. PubMed ID: 25573149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ release assay vs. tuberculin skin test for tuberculosis screening in exposed healthcare workers: a longitudinal multicenter comparative study.
    Lucet JC; Abiteboul D; Estellat C; Roy C; Chollet-Martin S; Tubach F; Carcelain G;
    Infect Control Hosp Epidemiol; 2015 May; 36(5):569-74. PubMed ID: 25682769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.
    Mandalakas AM; Hesseling AC; Gie RP; Schaaf HS; Marais BJ; Sinanovic E
    Thorax; 2013 Mar; 68(3):247-55. PubMed ID: 22717944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
    Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A
    Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
    Diel R; Nienhaus A; Loddenkemper R
    Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis.
    Mancuso JD; Niebuhr DW; Frick KD; Keep LW; Anderson KM
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1223-30, i. PubMed ID: 21943850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers.
    Nienhaus A; Ringshausen FC; Costa JT; Schablon A; Tripodi D
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):37-48. PubMed ID: 23428101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI.
    Oxlade O; Pinto M; Trajman A; Menzies D
    PLoS One; 2013; 8(3):e56044. PubMed ID: 23505412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update of the guidelines of the Israeli Association of Rheumatology for the prevention of tuberculosis in patients treated with TNF-alpha blockers].
    Balbir-Gurman A; Lidgi M; Elkayam O
    Harefuah; 2014 Jun; 153(6):359-61, 366. PubMed ID: 25095612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Tuberculosis in Health Care Workers: Experience in an Italian Teaching Hospital.
    Napoli C; Ferretti F; Di Ninno F; Orioli R; Marani A; Sarlo MG; Prestigiacomo C; De Luca A; Orsi GB
    Biomed Res Int; 2017; 2017():7538037. PubMed ID: 28337457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of adding an IGRA to the TST to screen for latent tuberculous infection in Greek health care workers.
    Charisis A; Tatsioni A; Gartzonika C; Gogali A; Archimandriti D; Katsanos C; Efthymiou A; Katsenos S; Daskalopoulos G; Levidiotou S; Constantopoulos SH; Konstantinidis AK
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1040-6. PubMed ID: 25189550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost-effectiveness of screening for latent tuberculosis in healthcare workers].
    Diomedi A
    Rev Chilena Infectol; 2013 Jun; 30(3):330. PubMed ID: 23877785
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.